Atlas Trials

A Phase II Safety and Tolerability Study of TCB008 in Patients With COVID-19

Clinical trial NCT04834128 · WITHDRAWN

Trial details

NCT number
NCT04834128
Sponsor
TC Biopharm
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
COVID - 19
Start date
2021-12-13
Primary completion
2022-04-13
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.